The Journal of Hematology Oncology Pharmacy (JHOP) seeks to provide hematology and oncology pharmacy practitioners and other hematology oncology professionals

JHOP provides hematology and oncology pharmacy practitioners and other hematology oncology professionals with Original Research and Review Articles to help them optimize drug therapy …

Azacitidine in Peripheral T-Cell Lymphoma: Prime Time for Epigenetic Modification?

JHOP The Journal of Hematology Oncology Pharmacy is an independent, peer-reviewed journal founded in 2011 to provide hematology and oncology pharmacy practitioners and other …

The Journal of Hematology Oncology Pharmacy (JHOP) seeks to provide hematology and oncology pharmacy practitioners and other hematology oncology professionals with high …

Issues - The Journal of Hematology Oncology Pharmacy ... 20252024

Adverse Events Antibiotics Antibody–Drug Conjugates Anticoagulants Biosimilars Bispecific Antibodies Cancer Types CAR T-Cell Therapy Case Reports CDK4/6 Inhibitors Checkpoint …

JHOP is an open access journal that requires no fee to be published or to access the content online or in print. A user license manages the reuse of JHOP articles under the following …

Manuscripts are submitted via the Journal's online Editorial Manager submission portal (accessible here). To submit your manuscript to JHOP, you must: Ensure that your article …

JHOP DC is celebrating 21 years of ministry on Capitol Hill. We are committed to the corporate expression of prayer and equipping the next generation to shape history.